Immunic Market Cap from 2010 to 2024

IMUX Stock  USD 1.11  0.02  1.77%   
Immunic Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 48.7 M in 2024. During the period from 2010 to 2024, Immunic Market Cap regression line of annual values had r-squared of  0.63 and arithmetic mean of  264,610,212. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
51.2 M
Current Value
48.7 M
Quarterly Volatility
256.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.5 K, Interest Expense of 730.2 K or Other Operating Expenses of 54.8 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 1.46. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
  
Check out the analysis of Immunic Correlation against competitors.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Latest Immunic's Market Cap Growth Pattern

Below is the plot of the Market Cap of Immunic over the last few years. It is Immunic's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunic's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Immunic Market Cap Regression Statistics

Arithmetic Mean264,610,212
Geometric Mean110,921,587
Coefficient Of Variation96.87
Mean Deviation223,019,265
Median226,357,095
Standard Deviation256,331,544
Sample Variance65705.9T
Range586.2M
R-Value(0.80)
Mean Square Error25835.4T
R-Squared0.63
Significance0.0004
Slope(45,670,461)
Total Sum of Squares919882T

Immunic Market Cap History

202448.7 M
202351.2 M
202244.5 M
2021226.4 M
2020239.5 M
201974.9 M

About Immunic Financial Statements

Immunic investors use historical fundamental indicators, such as Immunic's Market Cap, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Market Cap51.2 M48.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.